3/6/2020
Dr. Bivins: ‘Prostate screenings save lives’
Published 9:35 pm Wednesday, March 4, 2020 All Pike County men, ages 40 and over, are encouraged to set aside as few minutes on Saturday to take a simple test that could save their lives. […]
2/14/2020
While chocolates, cards, and intimacy is nice, what’s a better way to show him how much you truly care than protecting his health?
Valentine’s Day is just around the corner. While it is customary for men to get women gifts for this special day, many women will be trying to figure out a way to show their man […]
1/9/2020
FDA approves enzalutamide (XTANDI) for metastatic castration-sensitive prostate cancer
“At UCA, we continue to drive state of the art care. As a clinical trial site, interested and qualifying patients had the opportunity to participate in the clinical trial which led to the recent FDA […]
1/6/2020
2019: A Year in Review – “Pardon our Progress”
If I could pick one word to describe UCA in 2019, it would be GROWTH! We started 2019 by moving our St. Vincent’s East location to the Pilot building. We also hired a full-time Physician […]
1/3/2020
Urologists Can Serve as Advocates for Men’s Health
Gynecologists have long been recognized as champions of women’s health care, and Eric Brewer MD, a physician with Urology Centers of Alabama, says urologists should play the same role for men. “Historically, men have not […]
12/18/2019
UCA Offers Free PSA Screenings at the Mike Slive Invitational
UCA partnered with the Mike Slive Foundation to offer free PSA blood screenings at the Mike Slive Invitational. As basketball fans enjoyed the game of Auburn vs. St. Louis University, we screened over 60 men […]
11/1/2019
Changing the Face of Men’s Health
Movember, or No Shave November, is a social movement that’s intended to spark conversations about men’s health, and it’s represented by the iconic mustache (or facial hair). Every November, men around the globe ditch their […]
10/9/2019
FDA Approves Apalutamide for Metastatic Castration-Sensitive Prostate Cancer
On September 17, 2019, the Food and Drug Administration approved apalutamide (ERLEADA, Janssen Biotech, Inc) for patients with metastatic castration-sensitive prostate cancer (mCSPC). Apalutamide was initially approved in 2018 for patients with non-metastatic castration-resistant prostate […]
9/26/2019
Your Sexual Health: What You Need to Know
It’s not uncommon to keep sexual dysfunction to yourself, but the truth is you are not alone. 31% of men and 43% of women report some degree of sexual dysfunction for many different reasons. But […]